SANDEEP KAUR: Open Payments
NPI 1316671902 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 46 payments from 9 companies in 2025. Trend: 2023 $403 · 2024 $821 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $178 |
| AstraZeneca Pharmaceuticals LP | 8 | $136 |
| GlaxoSmithKline, LLC. | 4 | $75 |
| Lilly USA, LLC | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $46 |
| PFIZER INC. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Novo Nordisk Inc | 1 | $26 |
| Eisai Inc. | 1 | $23 |
Products named: XIFAXAN, TRELEGY ELLIPTA, BREZTRI, MOUNJARO, AIRSUPRA, JARDIANCE, PREVNAR 20, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
